PL367208A1 - Bakterie kwasu mlekowego jako czynniki do leczenia i zapobiegania alergii - Google Patents

Bakterie kwasu mlekowego jako czynniki do leczenia i zapobiegania alergii

Info

Publication number
PL367208A1
PL367208A1 PL02367208A PL36720802A PL367208A1 PL 367208 A1 PL367208 A1 PL 367208A1 PL 02367208 A PL02367208 A PL 02367208A PL 36720802 A PL36720802 A PL 36720802A PL 367208 A1 PL367208 A1 PL 367208A1
Authority
PL
Poland
Prior art keywords
agents
treating
lactic acid
acid bacteria
preventing allergy
Prior art date
Application number
PL02367208A
Other languages
English (en)
Inventor
Beda M. Stadler
Monique Vogel
Jacques-Edouard Germond
Rodolph Fritsche
Original Assignee
Societe Des Produits Nestle S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe Des Produits Nestle S.A. filed Critical Societe Des Produits Nestle S.A.
Publication of PL367208A1 publication Critical patent/PL367208A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Husbandry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Physiology (AREA)
  • Birds (AREA)
  • Wood Science & Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL02367208A 2001-03-02 2002-03-04 Bakterie kwasu mlekowego jako czynniki do leczenia i zapobiegania alergii PL367208A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01105138A EP1239032A1 (en) 2001-03-02 2001-03-02 Lactic acid bacteria as agents for treating and preventing allergy

Publications (1)

Publication Number Publication Date
PL367208A1 true PL367208A1 (pl) 2005-02-21

Family

ID=8176657

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02367208A PL367208A1 (pl) 2001-03-02 2002-03-04 Bakterie kwasu mlekowego jako czynniki do leczenia i zapobiegania alergii

Country Status (17)

Country Link
US (1) US7235395B2 (pl)
EP (2) EP1239032A1 (pl)
JP (1) JP2004528034A (pl)
KR (2) KR20030082950A (pl)
CN (1) CN1505678A (pl)
AR (1) AR035761A1 (pl)
AU (1) AU2002256639B2 (pl)
BR (1) BR0207749A (pl)
CA (1) CA2438833A1 (pl)
IL (1) IL157468A0 (pl)
MX (1) MXPA03007881A (pl)
NO (1) NO20033796L (pl)
NZ (1) NZ527861A (pl)
PL (1) PL367208A1 (pl)
RU (1) RU2312892C2 (pl)
WO (1) WO2002086102A1 (pl)
ZA (1) ZA200307680B (pl)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004112773A1 (fr) * 2003-04-24 2004-12-29 Shin-Jen Shiao Compositions pharmaceutiques utilisees pour le traitement de maladie immune et amelioration
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US7955834B2 (en) 2004-06-03 2011-06-07 Biogaia Ab Method for improved breast milk feeding to reduce the risk of allergy
US7862808B2 (en) * 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
US8252314B2 (en) 2004-09-24 2012-08-28 Hill's Pet Nutrition, Inc. Hypoallergenic composition
JP4974881B2 (ja) * 2005-03-03 2012-07-11 株式会社明治 免疫機能調整剤
US20060233762A1 (en) * 2005-04-15 2006-10-19 Mcmahon Robert J Method for treating or preventing systemic inflammation in formula-fed infants
US7303745B2 (en) * 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
CA2607949C (en) 2005-05-31 2012-09-25 Thomas William-Maxwell Boileau Feline probiotic bifidobacteria
DK1880001T3 (da) 2005-05-31 2011-09-12 Iams Company Feline probiotiske lactobacilli
JP2007300849A (ja) * 2006-05-11 2007-11-22 Oji Paper Co Ltd ペットフード
AU2008211600B8 (en) 2007-02-01 2014-02-13 Mars, Incorporated Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts
CN102028224B (zh) * 2007-06-21 2012-12-26 东宇生物科技股份有限公司 抗过敏的乳酸菌
KR100913405B1 (ko) * 2008-03-25 2009-08-21 광주과학기술원 Ｔｈ２－매개 면역 질환의 예방 또는 치료용 조성물
JP5150722B2 (ja) 2008-04-25 2013-02-27 亀田製菓株式会社 抗アレルギー作用を有する新規乳酸菌と、該乳酸菌を含む抗アレルギー剤、食品及び医薬品組成物と、前記抗アレルギー剤の製造方法
US9771199B2 (en) * 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
JP2012502026A (ja) * 2008-09-04 2012-01-26 オーエム ファルマ ラクトバチルス属細菌の免疫調節抽出物及びその製造法と使用法
US20100055082A1 (en) * 2008-09-04 2010-03-04 Jacques Alain Bauer Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof
CA2761573A1 (en) * 2009-05-11 2010-11-18 Nestec S.A. Bifidobacterium longum ncc2705 (cncm i-2618) and immune disorders
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
CA2770099A1 (en) * 2009-08-18 2011-02-24 Nestec S.A. A nutritional composition comprising lactococcus strains and reducing allergy symptoms, especially in infants and children.
KR20130041164A (ko) 2010-07-09 2013-04-24 스미또모 가가꾸 가부시끼가이샤 올레핀 산화물의 제조 방법
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
KR102038679B1 (ko) * 2018-01-12 2019-10-30 (주)지아이이노베이션 프로바이오틱스 및 IgE에 결합능이 있는 폴리펩티드를 포함하는 조성물 및 이의 용도
WO2024081219A1 (en) 2022-10-14 2024-04-18 Csp Technologies, Inc. Container and method for storing and stabilizing moisture sensitive products

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242821A (en) 1989-07-10 1993-09-07 Valio, Finnish Co-Operative Dairies' Association Lactococcus promoter and signal sequences for expression in bacteria
GB9006400D0 (en) 1990-03-22 1990-05-23 Ciba Geigy Ag Bacterial vectors
US6737521B1 (en) * 1990-05-11 2004-05-18 The Rockefeller University Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria
AU652920B2 (en) 1990-08-30 1994-09-15 Valio Ltd. Promoter probe vectors, able to replicate in E.coli, B.subtilis, lactococci and lactobacillus as well as uses thereof
GB9125695D0 (en) 1991-12-03 1992-01-29 Mastavac Limited Medical preparations
GB9400650D0 (en) * 1994-01-14 1994-03-09 Smithkline Beecham Biolog Expression of surface lazer proteins
AU2149495A (en) 1995-04-11 1996-10-30 Nederlandse Organisatie Voor Toegepast- Natuurwetenschappelijk Onderzoek Tno Method for the construction of vectors for lactic acid bacte ria like lactobacillus such that the bacteria can efficientl y express, secrete and display proteins at the surface
GB9518323D0 (en) * 1995-09-07 1995-11-08 Steidler Lothar Materials and methods relating to the attachment and display of substances on cell surfaces
ES2190799T5 (es) * 1996-03-01 2008-08-16 Novartis Ag Inmunogenos peptidicos para vacunacion y tratamiento contra la alergia.
JPH09234078A (ja) 1996-03-04 1997-09-09 Meiji Milk Prod Co Ltd 乳酸菌用分泌ベクター及び該ベクターを用いたタンパク質の製造方法
NZ334521A (en) * 1996-09-06 2000-03-27 Bioteknologisk Inst A lactic acid bacterial regulatable expression system
US6835550B1 (en) * 1998-04-15 2004-12-28 Genencor International, Inc. Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
US6642011B2 (en) * 1998-04-15 2003-11-04 Genencor International, Inc. Human protease and use of such protease for pharmaceutical applications and for reducing the allergenicity of non-human proteins
GB9908533D0 (en) * 1999-04-14 1999-06-09 Novartis Ag Organic compounds
JP2004514424A (ja) * 2000-09-25 2004-05-20 ソシエテ　デ　プロデユイ　ネツスル　ソシエテ　アノニム アレルギー反応を起こす個人の傾向を減少させることができる乳酸菌
EP1356073B1 (en) * 2000-10-20 2009-11-25 Bioneer A/S Fermentation method for production of heterologous gene products in lactic acid bacteria
EP1343894A4 (en) * 2000-11-02 2005-05-04 Univ Singapore AOPB GENE, PROTEIN, HOMOLOGISTS, FRAGMENTS AND VARIANTS THEREOF, AND THE USE THEREOF FOR PRESENTATION ON THE CELL SURFACE

Also Published As

Publication number Publication date
NO20033796L (no) 2003-10-31
CA2438833A1 (en) 2002-10-31
MXPA03007881A (es) 2003-12-04
EP1239032A1 (en) 2002-09-11
NZ527861A (en) 2005-02-25
RU2003129265A (ru) 2005-04-10
WO2002086102A1 (en) 2002-10-31
BR0207749A (pt) 2004-06-01
EP1370640A1 (en) 2003-12-17
CN1505678A (zh) 2004-06-16
AR035761A1 (es) 2004-07-07
KR20080111172A (ko) 2008-12-22
NO20033796D0 (no) 2003-08-26
ZA200307680B (en) 2005-01-13
IL157468A0 (en) 2004-03-28
US20040265290A1 (en) 2004-12-30
US7235395B2 (en) 2007-06-26
AU2002256639B2 (en) 2006-10-19
KR20030082950A (ko) 2003-10-23
JP2004528034A (ja) 2004-09-16
RU2312892C2 (ru) 2007-12-20

Similar Documents

Publication Publication Date Title
IL157468A0 (en) Lactic acid bacteria as agents for treating and preventing allergy
GB0110288D0 (en) Composition and treatment method
EP1416961A4 (en) COMPOSITION AND METHOD FOR THE TREATMENT OF A DISEASE
PL369237A1 (pl) Mikroorganizmy do traktowania gleby i sposób ich otrzymywania
GB0512558D0 (en) Microorganisms for well treatment
HK1061212A1 (en) Pyranoindazoles and their use for the treatment ofglaucoma
IL152553A0 (en) Compounds and methods for the treatment and prevention of bacterial infection
AU2002367023A8 (en) Compositions and methods for treating heart failure
EP1461047A4 (en) COMPOSITIONS AND METHODS FOR TREATING ANIMALS
AU2002365057A8 (en) Compositions and methods for treating heart failure
WO2003063725A3 (en) Methods of preventing and treating flavivirus infection in animals
AP2002002483A0 (en) Lactic acid bacteria for the treatment and/or prophylaxix of giardasis
IL151596A0 (en) Use of lactic acid bacterium for the treatment of peritonitis
AU2003239132A8 (en) Methods and compositions for preventing and treating microbial infections
HUP0401913A3 (en) Medicine for preventing and treating bromhidrosis
AU2002349268A1 (en) Medicine for preventing and treating bromidrosis
AU2003259202A8 (en) Compositions and methods for treating and preventing infection
EP1481691A4 (en) STERILIZER AND STERILIZATION METHOD
EP1409640A4 (en) ADAPTATION OF BACTERIA FOR USE IN LAUGH
IL161162A0 (en) Methods for preventing and treating bone loss with steroid compounds
AU2003258176A8 (en) Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
GB2399500B (en) Composition and method for treatment of wounds
AU2003258177A8 (en) Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
AU2003304316A8 (en) Compounds and methods for the treatment and prevention of bacterial infection
GB2413797B (en) Microorganisms for well treatment

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)